Label Changes for:

Colazal (balsalazide disodium) Capsules

July 2008

Changes have been made to the PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.


Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

Sections Modified

USE IN SPECIFIC POPULATIONS

  • Pediatric Use

ADVERSE REACTIONS

  • Postmarketing Experience
    • Hepatic

The July 2008 Label not available at this site.

Hide
(web5)